Inventor
AMBLARD FRANCK
US15 patents
⚠️ This page may combine multiple inventors who share the name “AMBLARD FRANCK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UNIV EMORY
8 patentsUS11207370B2Dec 28, 2021
Peptidomimetics for the treatment of coronavirus and picornavirus infections
UNIV EMORY19 citations90
US11021513B2Jun 1, 2021
Peptidomimetics for the treatment of norovirus infection
UNIV EMORY19 citations89
US10752584B2Aug 25, 2020
Elimination of hepatitis B virus with antiviral agents
UNIV EMORY3 citations65
US12268723B2Apr 8, 2025
Peptidomimetics for the treatment of coronavirus and picorna virus infections
UNIV EMORY0 citations59
US11963972B2Apr 23, 2024
Antiviral agents and nucleoside analogs for treatment of Zika virus
UNIV EMORY0 citations57
US11859014B2Jan 2, 2024
Peptidomimetics for the treatment of Norovirus infection
UNIV EMORY0 citations57
US11629125B2Apr 18, 2023
Elimination of hepatitis b virus with antiviral agents
UNIV EMORY0 citations55
US12318393B2Jun 3, 2025
Modulators of orphan nuclear receptors for NASH and other metabolic disorders
UNIV EMORY0 citations48
COCRYSTAL PHARMA INC
4 patentsUS9809616B2Nov 7, 2017
Pyrimidine nucleosides and their monophosphate prodrugs for the treatment of viral infections and cancer
COCRYSTAL PHARMA INC15 citations83
US9181227B2Nov 10, 2015
Potent and selective inhibitors of hepatitis C virus
COCRYSTAL PHARMA INC8 citations82
US9926295B2Mar 27, 2018
Potent and selective inhibitors of hepatitis C virus
COCRYSTAL PHARMA INC0 citations40
US10011629B2Jul 3, 2018
Nucleoside analogs for treatment of the flaviviridae family of viruses and cancer
COCRYSTAL PHARMA INC0 citations37